NO20031914D0 - Inhalable solution formulation containing a tiotropium salt - Google Patents

Inhalable solution formulation containing a tiotropium salt

Info

Publication number
NO20031914D0
NO20031914D0 NO20031914A NO20031914A NO20031914D0 NO 20031914 D0 NO20031914 D0 NO 20031914D0 NO 20031914 A NO20031914 A NO 20031914A NO 20031914 A NO20031914 A NO 20031914A NO 20031914 D0 NO20031914 D0 NO 20031914D0
Authority
NO
Norway
Prior art keywords
formulation containing
solution formulation
tiotropium salt
inhalable solution
inhalable
Prior art date
Application number
NO20031914A
Other languages
Norwegian (no)
Other versions
NO332524B1 (en
NO20031914L (en
Inventor
Karin Drechsel
Barbara Niklaus-Humke
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7661727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031914(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20031914D0 publication Critical patent/NO20031914D0/en
Publication of NO20031914L publication Critical patent/NO20031914L/en
Publication of NO332524B1 publication Critical patent/NO332524B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20031914A 2000-10-31 2003-04-29 Inhalable solution formulation containing a tiotropium salt, such preparations for use as a medicament and the use thereof for the manufacture of medicaments for the treatment of disease NO332524B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10054042 2000-10-31
PCT/EP2001/012296 WO2002036591A2 (en) 2000-10-31 2001-10-24 Inhalative solution formulation containing a tiotropium salt

Publications (3)

Publication Number Publication Date
NO20031914D0 true NO20031914D0 (en) 2003-04-29
NO20031914L NO20031914L (en) 2003-06-23
NO332524B1 NO332524B1 (en) 2012-10-08

Family

ID=7661727

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031914A NO332524B1 (en) 2000-10-31 2003-04-29 Inhalable solution formulation containing a tiotropium salt, such preparations for use as a medicament and the use thereof for the manufacture of medicaments for the treatment of disease

Country Status (33)

Country Link
EP (1) EP1335729A2 (en)
JP (1) JP4559703B2 (en)
KR (1) KR100983208B1 (en)
CN (1) CN1237970C (en)
AR (1) AR038765A1 (en)
AU (2) AU2174102A (en)
BG (1) BG66425B1 (en)
BR (1) BR0115016A (en)
CA (1) CA2427583C (en)
CZ (1) CZ305033B6 (en)
DE (1) DE10152369A1 (en)
EA (1) EA009068B1 (en)
EC (1) ECSP034570A (en)
EE (1) EE05343B1 (en)
HK (1) HK1060569A1 (en)
HR (1) HRP20030337A2 (en)
HU (1) HUP0301377A3 (en)
IL (2) IL155676A0 (en)
ME (1) ME00242B (en)
MX (1) MXPA03003750A (en)
MY (1) MY132777A (en)
NO (1) NO332524B1 (en)
NZ (1) NZ526024A (en)
PE (1) PE20020518A1 (en)
PL (1) PL361001A1 (en)
SA (1) SA01220503B1 (en)
SK (1) SK288031B6 (en)
TW (1) TWI296934B (en)
UA (1) UA76435C2 (en)
UY (1) UY26991A1 (en)
WO (1) WO2002036591A2 (en)
YU (1) YU33103A (en)
ZA (1) ZA200303045B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070092334A (en) 2000-04-28 2007-09-12 코산 바이오사이언시즈, 인코포레이티드 Production of polyketides
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
CA2544733A1 (en) * 2003-10-09 2005-04-21 Inverseon, Inc. Methods for treating diseases and conditions with inverse agonists and for screening for agents acting as inverse agonists
SE0303269L (en) * 2003-12-03 2005-06-04 Microdrug Ag Medical product
MX2007011273A (en) * 2005-03-16 2007-11-08 Meda Pharma Gmbh & Co Kg The combination of anticholinergics and leukotriene recptor antagonists for the treatment of repiratory diseases.
AU2007267523B2 (en) * 2006-05-26 2012-02-09 Dey, L.P. Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
CN100446770C (en) * 2007-01-10 2008-12-31 上海现代药物制剂工程研究中心有限公司 Water aerosol containing beclomethasone dipropionate
TR200907237A2 (en) * 2009-09-23 2011-04-21 Bi̇lgi̇ç Mahmut Tiotropium dry powder combination
CN111936124A (en) * 2018-07-26 2020-11-13 四川海思科制药有限公司 Aerosol pharmaceutical composition containing glycopyrronium salt and indacaterol salt, and preparation method and application thereof
WO2020019953A1 (en) * 2018-07-26 2020-01-30 四川海思科制药有限公司 Aerosol pharmaceutical composition containing a glycopyrrolate salt, preparation method therefor, and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE4203306A1 (en) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh ASTHMA OR PULMONAL AEROSOL PREPARATIONS WITH LECITHIN
TW537903B (en) * 1995-06-27 2003-06-21 Boehringer Ingelheim Kg New stable pharmaceutical preparation for producing propellant gas-free aerosols
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
EP0954318A1 (en) * 1996-06-04 1999-11-10 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
DE19653969A1 (en) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg New aqueous pharmaceutical preparation for the production of propellant-free aerosols
JPH10298107A (en) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd Pharmaceutical composition
NZ509489A (en) * 1998-08-04 2002-10-25 Jago Res A Medicinal aerosol formulations comprising cromoglycic acid and/or nedocromil
DE19847968A1 (en) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Separate storage of an active material and a solvent comprises a closure cap and a container, with a chamber attached to the unit.

Also Published As

Publication number Publication date
JP2004523482A (en) 2004-08-05
UY26991A1 (en) 2002-06-20
BR0115016A (en) 2005-05-03
KR100983208B1 (en) 2010-09-20
WO2002036591A3 (en) 2002-07-25
SA01220503B1 (en) 2007-03-10
BG107726A (en) 2004-11-30
JP4559703B2 (en) 2010-10-13
SK5262003A3 (en) 2003-10-07
IL155676A (en) 2012-05-31
NO332524B1 (en) 2012-10-08
CA2427583A1 (en) 2002-05-10
EE200300202A (en) 2003-10-15
ECSP034570A (en) 2003-06-25
AU2002221741B2 (en) 2007-04-05
PL361001A1 (en) 2004-09-20
CZ305033B6 (en) 2015-04-08
PE20020518A1 (en) 2002-07-12
HK1060569A1 (en) 2004-08-13
AU2174102A (en) 2002-05-15
NZ526024A (en) 2005-10-28
KR20040010552A (en) 2004-01-31
HUP0301377A2 (en) 2003-10-28
MY132777A (en) 2007-10-31
AR038765A1 (en) 2005-01-26
SK288031B6 (en) 2012-12-03
TWI296934B (en) 2008-05-21
NO20031914L (en) 2003-06-23
EE05343B1 (en) 2010-10-15
MXPA03003750A (en) 2004-10-15
MEP40708A (en) 2011-02-10
ME00242B (en) 2011-05-10
CN1237970C (en) 2006-01-25
BG66425B1 (en) 2014-04-30
UA76435C2 (en) 2006-08-15
EP1335729A2 (en) 2003-08-20
ZA200303045B (en) 2004-04-22
CA2427583C (en) 2008-02-12
IL155676A0 (en) 2003-11-23
HUP0301377A3 (en) 2005-12-28
YU33103A (en) 2006-05-25
EA200300483A1 (en) 2003-12-25
CN1473044A (en) 2004-02-04
WO2002036591A2 (en) 2002-05-10
CZ20031487A3 (en) 2003-09-17
HRP20030337A2 (en) 2005-04-30
EA009068B1 (en) 2007-10-26
DE10152369A1 (en) 2002-05-08

Similar Documents

Publication Publication Date Title
EE200200428A (en) Innovative inhalation powder containing tiotropium
EE200200656A (en) Tropane derivatives for therapeutic use
ATE359064T1 (en) PHARMACEUTICAL TRAMADOL SALTS
EE05063B1 (en) A pharmaceutical preparation containing a benzamide derivative
CY2009009I2 (en) STABLE PHARMACEUTICAL PHARMACEUTICAL SOLUTION FORMS FOR PRESSURE METERED DOSE INHALATION DEVICES
ATE395053T1 (en) PHARMACEUTICAL SALTS OF 1-PHENYL-3-DIMETHYLAMINO-PROPANE COMPOUNDS
DE60141149D1 (en) Medical inhalation device
NO20032909D0 (en) Glucopyranosyloxypyrazole derivatives as well as their drug use
FIU20000164U0 (en) A new pharmaceutical formulation
ATE320244T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AMLODIPINMALEATE
DK1299095T3 (en) Clear aqueous anesthetic preparation
EE200200568A (en) Therapeutic diphenylether compounds
NO20031914D0 (en) Inhalable solution formulation containing a tiotropium salt
NO20031911D0 (en) Inhalation solution formulation with a tiotropium salt
AU2002221741A1 (en) Inhalative solution formulation containing a tiotropium salt
EE200200073A (en) A pharmaceutical preparation containing a benzamide derivative
AU2002221738A1 (en) Inhalative solution formulation containing a tiotropium salt
EE200300045A (en) Crystalline drug substance
DE60001768T2 (en) Aqueous pharmaceutical preparation containing tezosentan

Legal Events

Date Code Title Description
MK1K Patent expired